newsfilter
← Latest News
ACCESS Newswire·

Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering

TNON
  • Tenon Medical, Inc. (NASDAQ: TNON) closed its public offering on July 1, 2026, raising $4.2 million in aggregate gross proceeds before fees & expenses.
  • The offering included 11,052,631 shares of common stock (or pre-funded warrants) & common stock purchase warrants for up to 13,263,159 shares at $0.38 per unit.
  • The number of shares underlying the Common Warrants will increase to 16,578,949 if the Company completes a reverse stock split.
  • Net proceeds will fund repayment of convertible notes, commercial expansion, sales hiring, distribution network growth, clinical research, R&D, inventory increases, working capital, & general corporate purposes.
  • WallachBeth Capital LLC served as the sole placement agent, with Sichenzia Ross Ference Carmel LLP as counsel for Tenon & Sheppard, Mullin, Richter & Hampton LLP as counsel for WallachBeth.
  • Common Warrants are immediately exercisable at $0.38 per share, while pre-funded warrants are immediately exercisable at $0.001 per share until fully exercised.
  • Securities were issued pursuant to SEC-registered Form S-1 statements (File Nos. 333-296952 & 333-297142).
  • Tenon Medical focuses on treating sacro-pelvic disorders via its Catamaran™ SI Joint Fusion System & the acquired SImmetry+® SI Joint Fusion System.